Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: Biosafety as skin whitening agents

Journal of Dermatological Science

Volumn 55, Issue 3, 2009, Pages 179-184

  Hu, Zhi Ming ^a   Zhou, Qiong ^a   Lei, Tie Chi ^a   Ding, Shen Feng ^b   Xu, Shi Zheng ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b R and D Department   (China)

Author keywords

Arbutin; Cytotoxicity; Hydroquinone; Melanogenesis; Reactive oxygen species

Indexed keywords

ARBUTIN; GLUCOSAMINE DERIVATIVE; HYDROQUINONE; REACTIVE OXYGEN METABOLITE; TYROSINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BIOSAFETY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEPIGMENTATION; FEMALE; FLUORESCENCE ANALYSIS; MELANOCYTE; MELANOGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET A RADIATION;

ANIMALS; ANTIOXIDANTS; ARBUTIN; CELL LINE; HYDROQUINONES; MELANINS; MELANOCYTES; MICE; MICE, INBRED C57BL; MONOPHENOL MONOOXYGENASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SKIN PIGMENTATION; ULTRAVIOLET RAYS;

EID: 67650726505     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.06.003     Document Type: Article

References (21)

1. Nordlund J.J., Grimes P.E., and Ortonnes J.P. The safety of hydroquinone. J Eur Acad Dermatol Venereol 20 (2006) 781-787
2. Nakajima M., Shinoda I., Fukuwatari Y., and Hayasawa H. Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosianse activity. Pigment Cell Res 11 (1998) 12-17
3. Westerhof W., and Kooyers T.J. Hydroquinone and its analogues in dermatology-a potential health risk. J Cos Dermatol 4 (2005) 55-59
4. Levitt J. The safety of hydroquinone: a dermatologist's response to the 2006 Fedral Register. J Am Acad Dermatol 57 (2007) 854-872
5. Horita M., Wang D.H., Tsutsui K., et al. Involvement of oxidative stress in hydroquinone-induced cytotoxicity in catalase-deficient Escherichia coli mutants. Free Radic Res 39 (2005) 1035-1041
6. Hori I., Nihei K., and Kubo I. Structural criteria for depigmenting mechanism of arbutin. Phytothera Res 18 (2004) 475-479
7. Maeda K., and Arbtuin F.M. Mechanism of its depigmenting action in human melanocyte culture. J Pharmcol Exp Ther 276 (1996) 765-769
8. Bang S.H., Han S.J., and Kim D.H. Hydrolysis of arbutin to hydroqinone by human skin bacteria and its effect on antioxidant activity. J Cosmet Dermatol 7 (2008) 189-193
9. Boissy R.E., Visscher M., and deLong M.A. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol 14 (2005) 601-608
10. Jimenez M., Tsukamoto K., and Hearing V.J. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 266 (1991) 1147-1156
11. Bennet D.C., Cooper P.J., and Hart I.R. A line of non-tumorigenic moouse melanocytes, syngeneic with the B16 melanoma and requiring a tumor promoter for growth. Int J Cancer 39 (1987) 414-418
12. Lei T.C., Virador V.M., Vieira W.D., and Hearing V.J. A melanocyte-keratinocyte coculture model to assess regulators of pigmentation in vitro. Anal Biochem 305 (2002) 260-268
13. Gen J., Tang W., Wan X., Zhou Q., Wang X.J., Shen P., et al. Photoprotection of bacterial-derived melanin against ultraviolet A-induced cell death and its potential application as an active sunscreen. J Eur Acad Dermatol Venereol 22 (2008) 852-858
14. 2 accumulation by catalase reduction changes MAP kinase signaling in aged human skin in vivo. J Invest Dermatol 125 (2005) 221-229
15. Lei T.C., Virador V., Yasumoto K., Vieira W.D., Toyofuku K., and Hearing V.J. Stimulation of melanblast pigmentation by 8-methoxypsoralen: the involvement of microphthalmia-associated transcription factor, the protein kinase A signal pathway, and proteasome-mediated degradation. J Invest Dermatol 119 (2002) 1341-1349
16. Tadokoro T., Rouzaud F., Itami S., et al. The inhibitory effects of androgen and sex-hormone-binding globulin on the intracellular cAMP level and tyrosinase activity of normal human melanocytes. Pigment Cell Res 16 (2003) 190-197
17. Ando H., Kondoh H., Ichihashi M., and Hearing V.J. Approaches to identify inhibitors of melanin biosyntheses via the quality control of tyrosinase. J Invest Dermatol 127 (2007) 751-761
18. Zhu W., and Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Invest Dermatol Symp Proc 13 (2008) 20-24
19. Matsubayashi T., Sakaeda T., Kita T., et al. Effects of various storage conditions and alterations of antioxidant contents on chromatic aberration of hydroquinone ointment. Biol Pharm Bull 26 (2003) 120-122
20. Hamed S.H., Sirwiriyanont P., deLong M.A., et al. Comparative efficacy and safety of deoxyarbutin A new tyrosinase-inhibiting agent. J Cosmet Sci 57 (2006) 291-308
21. Sugimoto K., Nomura K., Nishimura T., et al. Syntheses of alpha-arbutin-alpha-glycosides and their inhibitory effects on human tyrosinase. J Biosci Bioeng 99 (2005) 272-276